products
The Clarimedix product is a light-based medical device in the form of a flexible LED patch applied over the region of interest. The Company’s development pipeline includes treatments for Cerebral Vasospasm, Raynaud’s Syndrome and Alzheimer’s Disease. By using a proprietary “formulation” of light developed by Clarimedix, the product is capable of triggering targeted, localized and controllable production of nitric oxide. This naturally-produced molecule is a well-known vasodilator and neurotransmitter capable of increasing blood flow, reducing vasoconstriction, reducing inflammation and improving oxygen delivery to areas that have been deprived.
The potential to positively impact these conditions with a non-invasive, non-systemic option is compelling. Physician satisfaction with current treatments in these areas is consistently low and the lack of near-term innovation forecasted offers the Clarimedix technology an unparalleled opportunity.
Benefits or our unique approach:
- Non-invasive dosing
- Localized therapy (avoids systemic side effects)
- Significantly lower cost and time of development than a typical drug
© Copyright 2012 Clarimedix, Inc. - All Rights Reserved
